These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 6282522
1. Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases. Shigeno C, Fukunaga M, Yamamoto I, Dokoh S, Morita R, Hino M, Torizuka K. Clin Nucl Med; 1982 Jun; 7(6):297-8. PubMed ID: 6282522 [No Abstract] [Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL. J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299 [Abstract] [Full Text] [Related]
3. The bone scan as a tumour marker in prostatic carcinoma. Chisholm GD, Stone AR, Beynon LL, Merrick MV. Eur Urol; 1982 Oct; 8(5):257-60. PubMed ID: 6288389 [Abstract] [Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL. J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298 [Abstract] [Full Text] [Related]
5. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine. Weber DA, Makler PT, Watson EE, Coffey JL, Thomas SR, London J. J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697 [No Abstract] [Full Text] [Related]
11. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS. Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810 [Abstract] [Full Text] [Related]
12. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate. Bell D, Millar AM, Grayshan R, Muir AL. Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991 [No Abstract] [Full Text] [Related]
13. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia. Armas R, Neumann R, Goldsmith SJ. J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070 [Abstract] [Full Text] [Related]
14. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. O'Driscoll CM, Baker F, Casey MJ, Duffy GJ. J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716 [Abstract] [Full Text] [Related]
15. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy]. Nakano S, Hasegawa Y, Kajita A, Nakamura S, Horai T, Ikegami H, Matuda M, Okamoto N, Nabeshima H, Doi O, Komatubara Y, Ishigami S. Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314 [No Abstract] [Full Text] [Related]
16. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate. Subramanian G, McAfee JG, Thomas FD, Feld TA, Zapf-Longo C, Palladino E. Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414 [Abstract] [Full Text] [Related]
17. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates. Logic JR, Meyer-Pavel CM, Blackman J. J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610 [No Abstract] [Full Text] [Related]
19. Uptake of Tc-99m sestamibi and Tc-99m MDP in anaplastic carcinoma of the thyroid (nondiagnostic CT and ultrasound scans). Montes TC, Muñoz C, Rivero JI, Mota JA, Pustilnik N, Garcia F. Clin Nucl Med; 1999 May; 24(5):355-6. PubMed ID: 10232478 [No Abstract] [Full Text] [Related]
20. New vistas on bone scintigraphy. Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]